Mesothelioma treatment and treatment options for advanced malignant mesothelioma are not limited to surgery and chemotherapy. Increased awareness of mesothelioma and other asbestos-caused diseases has led to an increase on medical research to cure and control asbestos-caused cancers and related asbestos heart and respiratory diseases. Although chemotherapy and surgery are the most common forms of treatment, participating in clinical trials can provide you with alternative mesothelioma treatment options.
Perhaps the most common clinical trials and mesothelioma treatment options for advanced malignant mesothelioma involve chemotherapy and drug combinations. Drugs produce a medical benefit by themselves, and they can produce a different benefit when combined with other drugs – a chemical reaction that produces a third result. Advanced malignant mesothelioma clinical studies with Cisplatin, now often used with chemotherapy, proved Cisplatin to be effective. Mesothelioma clinical trials with Gemcitabine proved Gemcitabine to be ineffective. However, mesothelioma clinical trials using Cisplatin and Gemcitabine together are proving to be even more promising. Finding the right drug combinations to slow tumor growth and contribute to improved pain management is one of the fastest paths to wide-spread availability of new mesothelioma treatment options.
Anti-angiogenic therapy is a biological therapy based on interfering with the blood vessels that the cancer needs to survive. Advanced malignant mesothelioma patients have a higher vascular endothelial growth factor than patients with other cancers. Anti-angiogenic therapies focus on natural body substances that affect the mesothelioma cancer’s growth, including the use of drugs made of these substances to inhibit cancer growth factors.
Immunotherapy is also classified as a biological therapy. Immunotherapy, as the name suggests, concentrates on building immunity to the cancer cells. Immunotherapy can involve vaccines, and in cases of mesothelioma, these are likely to be injected in the pleural region. IL-2 is made naturally by the body, and clinical trials have demonstrated its success at treating mesotheliomas in the early stages, mesothelioma stages one and two, but not effective in treating advanced malignant mesothelioma.
Photodynamic therapy has gained increase attention in many medical fields for various treatment options, including mesothelioma treatment. Photodynamic therapy uses light and heat to kill cancer cells. Unfortunately, clinical trials have not been successful with advanced mesothelioma patients, nor patients in the mesothelioma patients in stages one and two. It has been successful in treating other cancers.
Gene therapy, also referred to as molecular therapy, is an exciting and relatively new field of research being applied to mesothelioma treatment. Oncogenes contribute to the fast spreading of the cancer cells and tumor suppressor genes stop cells from spreading. The medical premise is to replace the genes in cancer cells with healthy genes. Gene therapy is also a biological therapy and explores using the body’s natural substances to treat mesothelioma stages.
Mesothelioma treatment for advanced malignant mesothelioma is slowly finding new mesothelioma treatment options. It takes years to evaluate the clinical significance of a clinical trial and medical research to prove that a mesothelioma treatment option is a promising and viable alternative. Thorough medical research on mesothelioma treatment contributes to safe medical treatment options being widely-available to the public. Mesothelioma in any of its stages is dangerous, but with researchers working together, mesothelioma treatment options will be safer and mesothelioma research will someday find a cure.